Trial Profile
A Phase 2, Randomized, Double-blind, Placebo-Controlled Efficacy, Pharmacokinetics and Safety Study of CA-008 (Vocacapsaicin) in Subjects Undergoing Total Knee Arthroplasty
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Feb 2022
Price :
$35
*
At a glance
- Drugs Vocacapsaicin (Primary)
- Indications Postoperative pain
- Focus Pharmacokinetics; Therapeutic Use
- Sponsors Concentric Analgesics
- 11 May 2021 According to Concentric Analgesics media release, David Leiman is lead investigator in the trial.
- 11 May 2021 According to Concentric Analgesics media release, result from this trial will be presented at the 46th Annual Regional Anesthesiology and Acute Pain Medicine (ASRA) Meeting on May 13, 2021 in Orlando, Florida.
- 22 Jul 2019 Status changed from active, no longer recruiting to completed.